Experts see better glucose rates using dapagliflozin as add-on

06/30/2011 | Medscape (free registration)

Adding dapagliflozin to metformin therapy enhanced the treatment's efficacy in lowering blood glucose levels in patients newly diagnosed with type 2 diabetes, experts reported at the annual meeting of the American Diabetes Association. One study found that about 52% of patients on metformin-dapagliflozin treatment had hemoglobin A1c levels of 7% or less compared to 34.6% and 22.5% in those who only took either metformin or dapagliflozin, respectively. A second study had similar results.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA